BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 11 filers reported holding BIOMX INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,035 | -53.1% | 150,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,205 | -34.1% | 150,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,345 | -44.2% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 150,000 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -77.3% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $22,000 | +46.7% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | -68.1% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $47,000 | -48.9% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $92,000 | -11.5% | 150,000 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $104,000 | -12.6% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $119,000 | +14.4% | 150,000 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $104,000 | +44.4% | 150,000 | 0.0% | 0.01% | +75.0% |
| Q2 2020 | $72,000 | -26.5% | 150,000 | 0.0% | 0.00% | -66.7% |
| Q1 2020 | $98,000 | +27.3% | 150,000 | 0.0% | 0.01% | +100.0% |
| Q4 2019 | $77,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,133,402 | $3,413,000 | 0.39% |
| MMCAP International Inc. SPC | 684,451 | $1,095,000 | 0.07% |
| Kepos Capital LP | 450,597 | $721,000 | 0.06% |
| Orbimed Advisors | 2,813,489 | $4,502,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 98,700 | $158,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 106,696 | $171,000 | 0.00% |
| J. Goldman & Co LP | 150,000 | $15,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31,106 | $50,000 | 0.00% |
| Renaissance Technologies | 76,300 | $122,000 | 0.00% |
| UBS Group AG | 7,217 | $12,000 | 0.00% |